Recent investigations focusing on Nexaph small protein chains, a innovative class of compounds exhibiting significant potential for targeting different illness processes. Distinct from conventional small molecule methods, these chains provide improved specificity and lesser off-target effects, enabling them a highly desirable pathway for future dru